Specific Cellular Therapeutic Technology (RGSCTT)

Ever Supreme Bio Technology has partnered up with a number of medical institutions.   One of the reasons is that DC treatment was approved by the Ministry of Health and Welfare in May and September of 2019 for treating 8 types of "Stage IV solid cancers" and "Stage I-III solid cancer after ineffective after standard treatment; we are the first biotechnology company that is being approved by the Ministry of Health and Welfare by providing dendritic cell to treat all stages of cancer patients.

■ The first cell production company to receive DC approval in Taiwan (May 15, 2019)
■ The only CMO that produce DC cell product for Stage I-III ineffective after standard treatment, and IV solid cancer
■ Among the total of 52 immune cancer therapy applications, Ever Supreme is summed up to 23 cases (updated on Jan 5, 2021).
■ Already assist 8 institutions to pass.